Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2809 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.47 USD | -3.14% | -7.14% | -29.43% | -29.02% | 538.21 M USD | ||
| 2813 |  RGNX REGENXBIO Inc. - Common Stock | 8.09 USD | +6.45% | +6.73% | -6.26% | -39.76% | 534.05 M USD | ||
| 2818 |  NGNE Neurogene Inc. - Common Stock | 26.50 USD | +2.44% | -1.67% | -29.35% | -9.93% | 530.30 M USD | ||
| 2842 |  PBYI Puma Biotechnology Inc - Common Stock | 9.97 USD | +1.63% | +0.30% | +10.78% | +90.27% | 514.65 M USD | ||
| 2848 |  ALT Altimmune, Inc. - Common Stock | 2.60 USD | -2.26% | -7.14% | -21.69% | -35.48% | 505.75 M USD | ||
| 2852 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.66 USD | +5.73% | -3.49% | -8.79% | -20.19% | 501.86 M USD | ||
| 2865 |  VALN Valneva SE - American Depositary Shares | 5.69 USD | -3.07% | -1.39% | -14.31% | -47.12% | 493.72 M USD | ||
| 2867 |  ARVN Arvinas, Inc. - Common Stock | 7.51 USD | +0.81% | 0.00% | -13.38% | -19.25% | 491.05 M USD | ||
| 2883 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.40 USD | -2.10% | -10.83% | -19.08% | -2.78% | 483.69 M USD | ||
| 2894 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 1.77 USD | -2.21% | -4.32% | -11.50% | 0.00% | 471.11 M USD | ||
| 2903 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 8.01 USD | -1.11% | -12.36% | -6.43% | +5.12% | 465.69 M USD | ||
| 2905 |  ASMB Assembly Biosciences, Inc. - Common Stock | 22.82 USD | -0.57% | -2.06% | -29.91% | -22.46% | 464.63 M USD | ||
| 2917 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.34 USD | -0.85% | -5.26% | -12.69% | +29.28% | 457.00 M USD | ||
| 2921 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 4.56 USD | +4.59% | +9.62% | -12.31% | -50.49% | 453.48 M USD | ||
| 2931 |  SLN Silence Therapeutics Plc - American Depository Share | 9.52 USD | -3.05% | -11.61% | -28.85% | +76.30% | 449.79 M USD | ||
| 2933 |  RZLT Rezolute, Inc. - Common Stock | 4.64 USD | +5.94% | +12.35% | +15.14% | -47.33% | 448.79 M USD | ||
| 2938 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 22.75 USD | +0.18% | +0.09% | -24.32% | +32.65% | 444.75 M USD | ||
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 8.61 USD | +1.53% | -0.12% | -6.92% | -16.73% | 442.01 M USD | ||
| 2955 |  EDIT Editas Medicine, Inc. - Common Stock | 2.84 USD | +3.27% | +10.08% | +2.53% | -32.22% | 436.17 M USD | ||
| 2961 |  ENTX Entera Bio Ltd. - Ordinary Shares | 2.50 USD | -0.40% | -13.49% | -11.35% | 0.00% | 432.85 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |